X-MAT ® constructs partial wall made entirely from coal-derived components
BLUEFIELD, WV, 2022-Jan-21 — /EPR Network/ — If you’ve ever built a masterpiece out of Legos, you know it always begins with a single block. X-MAT® [read full press release…]
R&d
Healthcare BPO Market to Reach USD 312.43 billion With Increasing Demand for Healthcare Outsourcing
Pune, India, 2020-Dec-16 — /EPR Network/ — According to the new market research report “ Healthcare BPO Market by Outsourcing Approaches, Pharmaceutical (R&D, Manufacturing, Sales [read full press release…]
Global Healthcare BPO Market | Increasing Consolidation in the Healthcare Industry
Pune, India, 2020-Aug-12 — /EPR Network/ — According to the new market research report “Healthcare BPO Market by Outsourcing Approaches, Pharmaceutical (R&D, Manufacturing, Sales and [read full press release…]
Healthcare BPO market is estimated to reach $312.43 billion by 2022 grow at a CAGR of 10.2%
In the current market scenario, there is a growing demand for healthcare BPO services. The objective of this report is to define, describe, and forecast [read full press release…]
Tuliplab undertakes advanced contract manufacturing of quality healthcare products to widespread clients
MUMBAI, India, 2017-Dec-04 — /EPR Network/ — Tuliplab’s contract manufacturing assists clients with the support of research, production, assembling, investigation of materials and the development [read full press release…]
Upadacitinib Launch: Market Opportunities, Outlook, Current Trends and Growth Factors – 2017
Albany, US, 2017-Sep-05 — /EPR Network/ — A new study by Market Research Hub (MRH) provides a detailed analysis on the prospects of Upadacitinib drug, which [read full press release…]
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) – Pipeline Assessment and Therapeutic Activities Reviewed in H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — According to the recently published report ‘Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) – Pipeline Review, H2 2017‘; [read full press release…]
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) – Pipeline Review With Ongoing Trends and Therapeutics Developments, H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis [read full press release…]
DNA Gyrase Subunit B (EC 5.99.1.3) – Latest Research and Pipeline Review, H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — DNA Gyrase Subunit B (EC 5.99.1.3) pipeline Target constitutes close to 6 molecules. Out of which approximately 6 molecules [read full press release…]
Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) – Latest Insights on Research and Therapeutics Development, Pipeline Review, H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — According to the recently published report ‘Neutrophil Elastase – Pipeline Review, H2 2017‘; Neutrophil Elastase (Bone Marrow Serine [read full press release…]
Glutamate Carboxypeptidase 2 (Folate Hydrolase 1) – Therapeutic Activities, Pipeline Overview and R&D Insights H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or [read full press release…]
Caspase 9 (Apoptotic Protease Mch 6) – Reviewed by Company, Profiled Drugs and Therapeutic Development in H2 2017
Albany, US, 2017-Sep-01 — /EPR Network/ — Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or [read full press release…]
